This is an AMP page which is for mobile devices.

View Non AMP page

Twitter

Link your Twitter Account to Market Wire News

When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.

Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / REGN - Regeneron is said to have declined a higher bid for 23andMe after Wojcicki's offer

REGN - Regeneron is said to have declined a higher bid for 23andMe after Wojcicki's offer

June, 17 2025 09:44 AM Regeneron Pharmaceuticals Inc.

2025-06-17 09:44:23 ET

More on Regeneron Pharmaceuticals, 23andMe

Regeneron Pharmaceuticals, Inc. (REGN) Presents at 46th Annual Goldman Sachs Global Healthcare Conference Transcript
Itepekimab Failure A Setback For Sanofi And Regeneron
Regeneron's 23andMe Steal - Smart Genetics Play That Won't Cure Near-Term Growth Pains
23andMe sold to non-profit headed by co-founder Anne Wojcicki
Sens. Sanders, King introduce bill to end prescription drug advertising

For further details see:

Regeneron is said to have declined a higher bid for 23andMe after Wojcicki's offer

Stock Information

Company Name:	Regeneron Pharmaceuticals Inc.
Stock Symbol:	REGN
Market:	NASDAQ
Website:	regeneron.com

REGN REGN Quote REGN Short REGN News REGN Articles REGN Message Board

Get REGN Alerts

News, Short Squeeze, Breakout and More Instantly...

Market Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.